2024 - Accelerating Early Phase Biologics from the Clinic to Commercialization

In this webinar, the expert speakers will discuss the important role that key technologies and processes play in expediting an early-phase biologics path to the clinic and beyond. 
The mammalian cell-based biomanufacturing industry continues to lead the market for biologics. These include monoclonal antibodies (mAbs), fusion proteins, antibody fragments, bispecific and bifunctional antibodies and antibody-drug conjugates (ADCs).
Read more...
Register for this webinar today to learn how to streamline the development and manufacturing of early-phase biologics by applying a quality by-design technique.
In this webinar, attendees will gain insights into:
How an established routine, expertise and single-use technologies can provide a solid foundation for success in antibody development
How a modular downstream process can be designed for plug-n-play flexibility while maintaining agility to meet development timelines
How scalable process trains can seamlessly take a biologic from benchtop to commercial scale manufacturing
How quality documentation can aid in quality improvements
How single-use technologies can enhance quick turnover, ease of implementation and time to market
Keywords: Drug Development, Biologics, Monoclonal Antibodies, Commercial Manufacturing, CDMO, Biologics Manufacturing, CDMO/CMO, Basic Research